Scutellarin Suppresses Platelet Aggregation and Stalls Lesional Progression in Mouse With Induced Endometriosis

Platelets play an important role in the development of endometriosis. Scutellarin is a flavonoid isolated from a medicinal herb traditionally used as a potent antiplatelet agent. In this study, we sought to evaluate its potential therapeutic effect, if any, in mice with induced endometriosis. Endometriosis was induced in 27 female Balb/c mice by intraperitoneal injection of uterine fragments. Two weeks after the induction, the 27 mice were randomly divided in equal sizes into 3 groups: untreated, which received only vehicle, and low-dose and high-dose groups, which received low- and high dose of scutellarin treatment. Hotplate test was administrated to all mice before endometriosis induction, and before and after the scutellarin treatment. Two weeks after the treatment, a blood sample was drawn before sacrifice and all lesions were harvested. The peripheral platelet activation rate and total lesion weight were assessed, and immunohistochemistry and histochemistry analyses were performed to evaluate the extent of proliferation, angiogenesis, fibroblast-to-myofibroblast transdifferentiation (FMT), and fibrosis in lesions. Compared with untreated mice, mice in both low-dose and high-dose groups had significantly reduced lesion weight and improved hyperalgesia. Scutellarin also reduced the peripheral-activated platelets rate and resulted in significantly reduced platelet aggregation, cellular proliferation, angiogenesis, the extent of FMT, and the extent of fibrosis in lesions. Thus, we conclude that scutellarin is efficacious in treating endometriosis in vivo by suppressing platelet aggregation, inhibiting proliferation, angiogenesis, and fibrogenesis, resulting in reduced lesion size and improved pain behavior. As such, scutellarin may be a potentially promising therapeutics for the treatment of endometriosis. Similar content being viewed by others

Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447): 1789–1799. Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometrio-sis: a committee opinion. Fertil Steril. 2014;101(4):927–935. Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15(4):441–461. Koga K, Takamura M, Fujii T, Osuga Y. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril. 2015;104(4):793–801. Garcia-Velasco JA, Somigliana E. Management of endometrio-mas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009;24(3):496–501. De Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet. 2010;376(9742): 730–738. Coccia ME, Rizzello F, Mariani G, Bulletti C, Palagiano A, Scar-selli G. Ovarian surgery for bilateral endometriomas influences age at menopause. Hum Reprod. 2011;26(11):3000–3007. Vercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi D, Somigliana E. Medical treatment of endometriosis-related pain. Best Pract Res Clin Obstet Gynaecol. 2018;51:68–91. Vercellini P, Crosignani P, Somigliana E, Vigano P, Frattaruolo MP, Fedele L. 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis. Hum Reprod. 2011;26(1): 3–13. Guo SW, Groothuis PG. Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis?. Hum Reprod Update. 2018;24(5):577–598. Brosens IA. Endometriosis–a disease because it is characterized by bleeding. Am J Obstet Gynecol. 1997;176(2):263–267. Guo SW, Ding D, Shen M, Liu X. Dating endometriotic ovarian cysts based on the content of cyst fluid and its potential clinical implications. Reprod Sci. 2015;22(7):873–883. Ding D, Liu X, Duan J, Guo SW. Platelets are an unindicted culprit in the development of endometriosis: clinical and experimental evidence. Hum Reprod. 2015;30(4):812–832. Guo SW. Fibrogenesis resulting from cyclic bleeding: the Holy Grail of the natural history of ectopic endometrium. Hum Reprod. 2018;33(3):353–356. Zhang Q, Duan J, Liu X, Guo SW. Platelets drive smooth muscle metaplasia and fibrogenesis in endometriosis through epithelial–mesenchymal transition and fibroblast-to-myofibroblast transdif-ferentiation. Mol Cell Endocrinol. 2016;428:1–16. Zhang Q, Duan J, Olson M, Fazleabas A, Guo SW. Cellular changes consistent with epithelial–mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the progression of experimental endometriosis in baboons. Reprod Sci. 2016;23(10):1409–1421. Zhang Q, Ding D, Liu X, Guo SW. Activated platelets induce estrogen receptor beta expression in endometriotic stromal cells. Gynecol Obstet Invest. 2015;80(3):187–192. Du Y, Liu X, Guo SW. Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms. Hum Reprod. 2017;32(4):794–810. Wu Q, Ding D, Liu X, Guo SW. Evidence for a hypercoagulable state in women with ovarian endometriomas. Reprod Sci. 2015;22(9):1107–1114. Ding D, Liu X, Guo SW. Further evidence for hypercoagulability in women with ovarian endometriomas. Reprod Sci. 2018;25(11): 1540–1548. doi:10.1177/1933719118799195 Guo SW, Ding D, Geng JG, Wang L, Liu X. P-selectin as a potential therapeutic target for endometriosis. Fertil Steril. 2015;103(4):990–1000e8. Guo SW, Ding D, Liu X. Anti-platelet therapy is efficacious in treating endometriosis induced in mouse. Reprod Biomed Online. 2016;33(4):484–499. Carnero A. High throughput screening in drug discovery. Clin Transl Oncol. 2006;8(7):482–490. Wang L, Ma Q. Clinical benefits and pharmacology ofscutellarin: a comprehensive review. Pharm Ther. 2018;190:105–127. Liu X, Cheng J, Zhang G, et al. Engineering yeast for the production of breviscapine by genomic analysis and synthetic biology approaches. Nat Commun. 2018;9(1):448. Luo P, Tan ZH, Zhang ZF, Zhang H, Liu XF, Mo ZJ. Scutellarin isolated from Erigeron multiradiatus inhibits high glucose-mediated vascular inflammation. Yakugaku Zasshi. 2008;128(9): 1293–1299. Ma JY, Jiang WW, Zhou ZT, Li JM, Wang HY. The promoting angiogenesis and anti-inflammation effect of scutellarin on polyglycolic acid scaffold of Balb/c mice model. J Asian Nat Prod Res. 2008;10(11–12):1147–1153. Tian X, Chang L, Ma G, et al. Delineation of platelet activation pathway of scutellarein revealed its intracellular target as protein kinase C. Biol Pharm Bullet. 2016;39(2):181–191. Hou L, Chen L, Fang L. Scutellarin inhibits proliferation, invasion, and tumorigenicity in human breast cancer cells by regulating HIPPO-YAP signaling pathway. Med Sci Monit. 2017;23:5130–5138. Ke Y, Bao T, Wu X, et al. Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity. Biochem Biophys Res Commun. 2017;483(1):509–515. Li H, Huang D, Gao Z, Chen Y, Zhang L, Zheng J. Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase-2 and -9 and alphavbeta6 integrin. Int J Oncol. 2013;42(5):1674–1681. Zhu PT, Mao M, Liu ZG, Tao L, Yan BC. Scutellarin suppresses human colorectal cancer metastasis and angiogenesis by targeting ephrinb2. Am J Transl Res. 2017;9(11):5094–104. Sun CY, Zhu Y, Li XF, et al. Scutellarin increases cisplatin-induced apoptosis and autophagy to overcome cisplatin resistance in non-small cell lung cancer via ERK/p53 and c-met/AKT signaling pathways. Front Pharmacol. 2018;9:92. Pan Z, Zhao W, Zhang X, et al. Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFbeta1 expression and activation of p38-MAPK and ERK1/ 2. Br J Pharmacol. 2011;162(3):688–700. Li Y, Liu YD, Chen SL, et al. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/ MAPK pathway. Mol Hum Reprod. 2018. KhoshdelRad N, Salehi Z, Mashayekhi F, Abbasi O, Mirzajani E. Soluble c-Met expression in the peritoneal fluid and serum of patients with different stages of endometriosis. Arch Gynecol Obstet. 2014;289(5):1107–1112. Choi J, Jo M, Lee E, Hwang S, Choi D. Aberrant PTEN expression in response to progesterone reduces endometriotic stromal cell apoptosis. Reproduction. 2017;153(1):11–21. Council NR. Guide for the Care and Use of LaboratoryAnimals. Washington, DC: National Academies Press; 1996. Somigliana E, Vigano P, Rossi G, Carinelli S, Vignali M, Panina-Bordignon P. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometrio-sis. Hum Reprod. 1999;14(12):2944–2950. Long Q, Liu X, Guo SW. Surgery accelerates the development of endometriosis in mouse. Am J Obstetr Gynecol. 2016;215(3):320.e1–320.e15. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659–661. Hu X, Teng S, He J, et al. Pharmacological basis for application of scutellarin in Alzheimer's disease: antioxidation and antiapopto-sis. Mol Med Rep. 2018;18(5):4289–4296. Sun C, Li C, Li X, et al. Scutellarin induces apoptosis and autop-hagy in NSCLC cells through ERK1/2 and AKT signaling pathways in vitro and in vivo. J Cancer. 2018;9(18):3247–3256. Lu Y, Nie J, Liu X, Zheng Y, Guo SW. Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod. 2010;25(4):1014–1025. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2016. Zhao T, Liu X, Zhen X, Guo SW. Levo-tetrahydropalmatine retards the growth of ectopic endometrial implants and alleviates generalized hyperalgesia in experimentally induced endometrio-sis in rats. Reprod Sci. 2011;18(1):28–45. Zheng Y, Liu X, Guo SW. Therapeutic potential of andrographo-lide for treating endometriosis. Hum Reprod. 2012;27(5): 1300–1313. Liu M, Liu X, Zhang Y, Guo SW. Valproic acid and progestin inhibit lesion growth and reduce hyperalgesia in experimentally induced endometriosis in rats. Reprod Sci. 2012;19(4): 360–373. Lien LM, Su CC, Hsu WH, et al. Mechanisms of andrographolide-induced platelet apoptosis in human platelets: regulatory roles of the extrinsic apoptotic pathway. Phytother Res. 2013;27(11):1671–1677. Davidson DC, Hirschman MP, Spinelli SL, et al. Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individuals. JImmunol. 2011;186(1):584–591. Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E. Platelets and wound healing. Front Biosci. 2008;13:3532–3548. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. JBiolChem. 1983;258:7155–7160. Guo SW, Du Y, Liu X. Endometriosis-derived stromal cells secrete thrombin and thromboxane A2, inducing platelet activation. Reprod Sci. 2016;23(8):1044–1052. Hu XM, Zhou MM, Hu XM, Zeng FD. Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion. Acta Pharmacol Sin. 2005;26(12): 1454–1459. Yang W, Lust RM, Bofferding A, Wingard CJ. Nitric oxide and catalase-sensitive relaxation by scutellarin in the mouse thoracic aorta. J Cardiovasc Pharmacol. 2009;53(1):66–76. Gonzalez-Ramos R, Donnez J, Defrere S, et al. Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis. Mol Hum Reprod. 2007;13(7):503–509. Gonzalez-Ramos R, van Langendonckt A, Defrere S, et al. Involvement of the nuclear factor-kappaB pathway in the pathogenesis of endometriosis. Fertil Steril. 2010;94(6): 1985–1994. Kaponis A, Iwabe T, Taniguchi F, et al. The role of NF-kappaB in endometriosis. Front Biosci (Schol Ed). 2012;4: 1213–1234. Wang YH, Geng L, Li H. Study on effect of scutellarin in resisting liver fibrosis in rats [in Chinese]. Zhongguo Zhong Yao Za Zhi. 2015;40(10):1999–2003. Zhou H, Chen X, Chen L, et al. Anti-fibrosis effect of scutellarin via inhibition of endothelial-mesenchymal transition on isoprenaline-induced myocardial fibrosis in rats. Molecules. 2014;19(10):15611–15623. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol. 2007;179(6):1311–1323. Froese AR, Shimbori C, Bellaye PS, et al. Stretch-induced activation of transforming growth factor-beta1 in pulmonary fibrosis. Am JRespir Crit Care Med. 2016;194(1):84–96. Matsuzaki S, Canis M, Pouly JL, Darcha C. Soft matrices inhibit cell proliferation and inactivate the fibrotic phenotype of deep endometriotic stromal cells in vitro. Hum Reprod. 2016;31(3): 541–553. Matsuzaki S, Darcha C, Pouly JL, Canis M. Effects of matrix stiffness on epithelial to mesenchymal transition-like processes of endometrial epithelial cells: implications for the pathogenesis of endometriosis. Sci Rep. 2017;7:44616. Michelson AD, Barnard MR, Krueger LA, Frelinger A [jrIII}, Furman MI. Evaluation of platelet function by flow cytometry. Methods. 2000;21(3):259–270. Zhang Q, Liu X, Guo SW. Progressive development of endome-triosis and its hindrance by anti-platelet treatment in mice with induced endometriosis. Reprod Biomed Online. 2017;34(2): 124–136. LiuX, Zhang Q, Guo SW. Histological and immunohistochemical characterization of the similarity and difference between ovarian endometriomas and deep infiltrating endometriosis. Reprod Sci. 2018;25(3):329–340. Author information Authors and Affiliations Corresponding authors Supplemental Material Supplemental Material Supplemental material for this article is available online. Rights and permissions About this article Cite this article Ding, D., Cai, X., Zheng, H. et al. Scutellarin Suppresses Platelet Aggregation and Stalls Lesional Progression in Mouse With Induced Endometriosis. Reprod. Sci. 26, 1417–1428 (2019). https://doi.org/10.1177/1933719118817661 Published: Version of record: Issue date: DOI: https://doi.org/10.1177/1933719118817661